ArticleEndocrine2026
Machine Learning-Driven Identification and In Vitro Validation of the APOBEC3B-ANLN Regulatory Axis in Adrenocortical Carcinoma.
Article in Endocrine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Machine Learning-Derived Sarcopenia Signature Identifies High-Risk Molecular State in T2D Skeletal Muscle.Cell biochemistry and biophysics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundAdrenocortical carcinoma (ACC) is a rare, aggressive malignancy with limited diagnostic and therapeutic options. APOBEC3B (A3B) has emerged as a mutational driver in several cancers, but its downstream mechanisms remain unclear. We aim to utilize bioinformatics methods, such as machine learning, to reveal the mechanism of A3B in ACC and verify and explore it in depth in vitro.
methodsThrough the comprehensive analysis of 311 samples, including differential expression analysis and weighted gene co-expression network analysis (WGCNA), we use the hub genes extracted from the key modules as the background for 113 machine learning methods. Genes with potential associations were evaluated using feature importance and SHAP analysis techniques, and in vitro studies included qRT-PCR, Western blotting, siRNA-mediated knockdown, overexpression rescue, scratch assays, and Transwell migration assays to assess effects on gene expression and cell motility.
resultsRandom Forest was selected as the optimal model and identified nine gene features centered on A3B and ANLN (AUC = 0.996). Knockout of the A3B gene significantly reduced the mRNA and protein levels of ANLN (p < 0.001). ANLN overexpression rescued the outcome. Compared with knockout alone, the cell migration distance and the number of migrating cells were restored (p < 0.001).
conclusionsOur comprehensive omics and experimental methods have revealed the A3B-ANLN axis as a key mechanism of ACC and also provided predictive models and potential targets for the early diagnosis and therapeutic intervention of ACC.
Indexed as
Identifiers
41540175What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.